News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
230,574 Results
Type
Article (13129)
Company Profile (24)
Press Release (217421)
Section
Business (71242)
Career Advice (1109)
Deals (14403)
Drug Delivery (39)
Drug Development (34436)
Employer Resources (46)
FDA (6566)
Job Trends (5769)
News (125067)
Policy (10307)
Tag
Academia (753)
Alliances (11056)
Alzheimer's disease (482)
Approvals (6577)
Artificial intelligence (58)
Bankruptcy (106)
Best Places to Work (4892)
Breast cancer (121)
Cancer (836)
Cardiovascular disease (64)
Career advice (881)
Cell therapy (131)
Clinical research (29089)
Collaboration (238)
Compensation (100)
COVID-19 (978)
Data (931)
Diabetes (91)
Diagnostics (2167)
Earnings (49274)
Employer resources (43)
Events (32134)
Executive appointments (156)
FDA (6923)
Funding (233)
Gene therapy (84)
GLP-1 (358)
Government (1498)
Healthcare (6756)
Infectious disease (1027)
Inflammatory bowel disease (44)
Interviews (193)
IPO (8363)
Job creations (1174)
Job search strategy (769)
Layoffs (141)
Legal (2074)
Lung cancer (134)
Lymphoma (71)
Manufacturing (98)
Medical device (4800)
Medtech (4802)
Mergers & acquisitions (6196)
Metabolic disorders (274)
Neuroscience (648)
NextGen Class of 2024 (2065)
Non-profit (1525)
Northern California (895)
Obesity (165)
Opinion (62)
Parkinson's disease (52)
People (8072)
Phase I (7738)
Phase II (12565)
Phase III (11188)
Pipeline (416)
Postmarket research (1211)
Preclinical (2583)
Radiopharmaceuticals (90)
Rare diseases (121)
Real estate (1318)
Regulatory (7376)
Research institute (772)
Resumes & cover letters (207)
Southern California (739)
Startups (1131)
United States (7287)
Vaccines (286)
Weight loss (121)
Date
Last 7 days (344)
Last 30 days (1448)
Last 365 days (16816)
2024 (16756)
2023 (16186)
2022 (20646)
2021 (20272)
2020 (19030)
2019 (16793)
2018 (12749)
2017 (11970)
2016 (10566)
2015 (12716)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (315)
Arizona (46)
Asia (14990)
Australia (2287)
California (1969)
Canada (727)
China (172)
Colorado (89)
Connecticut (127)
Delaware (69)
Europe (33115)
Florida (237)
Georgia (61)
Illinois (157)
Indiana (111)
Japan (59)
Maryland (267)
Massachusetts (1408)
Michigan (58)
Minnesota (93)
New Jersey (576)
New York (563)
North Carolina (296)
Northern California (895)
Ohio (50)
Pennsylvania (424)
South America (463)
Southern California (739)
Texas (300)
Utah (48)
Washington State (225)
230,574 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & Acquisitions
Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
By far, the largest acquisition of 2024 was Novo Holdings’ yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion. Outside of that, the leading pharmaceutical companies kept to less than $5 billion per deal.
December 11, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
December 16, 2024
·
3 min read
Press Releases
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
December 12, 2024
·
4 min read
Layoffs
The 5 Largest Biopharma Layoffs of 2024
While layoffs have slowed in the second half of the year, according to
BioSpace
data, companies including Bayer, Bristol Myers Squibb and Johnson & Johnson are cutting hundreds or even thousands of employees in 2024.
December 19, 2024
·
7 min read
·
Angela Gabriel
Neuroscience
5 Clinical Assets That Flopped in 2024
Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here,
BioSpace
looks at five clinical trial flops that stole headlines over the past 12 months.
December 16, 2024
·
6 min read
·
Heather McKenzie
Press Releases
Clinical Trial Management Systems Market Size to Worth USD 5.5 Billion By 2031
November 21, 2024
·
1 min read
Earnings
Catalent Misses Fiscal Q1 Revenue Expectations as Pressure Mounts on Novo Holdings’ $16.5B Buyout
The contract manufacturer fell short of Wall Street’s projections for its first quarter of fiscal 2025, which ended Sept. 30, 2024. The miss comes amid growing opposition to Novo Holdings’ proposed $16.5 billion acquisition of Catalent.
November 6, 2024
·
3 min read
·
Tristan Manalac
Pharm Country
JOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic Ventures
JOGO Health, a medtech company treating chronic pain and neuromuscular disorders, announced it has closed over $5.5 million in an investment round led by Hourglass Ventures.
June 18, 2024
·
2 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Huntington’s
5 Huntington’s Therapies to Watch
A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win. Here,
BioSpace
looks at five candidates that could change the trajectory for patients.
November 11, 2024
·
5 min read
·
Kate Goodwin
1 of 23,058
Next
